GSK3B and hepatocellular carcinoma: Above data showed the Wnt pathway was activated in sorafenib-resistant HCC (Fig. 1B), thus, the protein level of β-catenin and the phosphorylation level of GSK-3β were analyzed to identify whether the Wnt signaling activated in sorafenib-resistant HCC cells.